Tnf-Alpha Induction Of Il-6 In Alveolar Type Ii Epithelial Cells: Contributions Of Jnk/C-Jun/Ap-1 Element, C/Ebp Delta/C/Ebp Binding Site And Ikk/Nf-Kappa B P65/Kappa B Site
Chunguang Yan,Chunmin Deng,Xiufang Liu,Yutong Chen,Jiawei Ye,Rentian Cai,Yanfei Shen,Huifang Tang
DOI: https://doi.org/10.1016/j.molimm.2018.05.004
IF: 4.174
2018-01-01
Molecular Immunology
Abstract:Although participation of IL-6 in lung inflammation has been widely elucidated, the transcriptional regulation of its generation in alveolar type II cells stimulated by TNF-alpha remain unclear. Here, we find that TNF-alpha significantly induces IL-6 production, and TNF-alpha induction of IL-6 is mainly regulated at transcriptional level. Upon stimulated by TNF-alpha, Activator Protein-1 (AP-1)-mediated transcriptional activity is apparently increased in alveolar type II epithelial cells, which might be derived from elevated phosphorylation of JNK and subsequent activation of c-Jun. Either down-regulation of c-Jun or the AP-1 site mutation leads to significant reduction of IL-6 expression. In contrast, ectopic expression of c-Jun notably increases IL-6 generation. So, c-Jun, one of the AP-1 family members, plays a pivotal role in TNF-alpha-induced IL-6 generation. CCAAT/enhancer binding protein delta (C/EBP delta) expression is significantly amplified by TNF-alpha, which may contribute to the rise of C/EBP activity in alveolar type II cells. C/EBP delta shRNA treatment results in attenuation of IL-6 expression in the cells, which is consistent with data by introduction of mutations into the C/EBP site in the promoter. However, overexpression of C/EBP delta greatly increases the IL-6 promoter activity. In addition, data regarding another transactivator in the family-C/EBP beta show that it does not affect IL-6 production. We also find that the IKK/NF-kappa B p65 pathway is activated in TNF-alpha-treated alveolar type II epithelial cells, and plays an essential role in positive regulation of IL-6 expression in TNF-alpha-treated alveolar type II epithelial cells via knockdown or forced expression of NF-kappa B p65, or elimination of xB sites in the IL-6 promoter. Notably, IL-6 promoter-driven luciferase production in primary alveolar type II epithelial cells can also be increased by the ectopic expression of c-Jun, C/EBP delta, and NF-kappa B p65, respectively. Collectively, our data provide insights into molecular mechanism involved in IL-6 expression in alveolar type II epithelial cells on TNF-alpha treatment, which provides a theoretical basis for specific inhibition of IL-6 production at the transcriptional level.